Search
for
Sort by
Research 481–510 of 660
- Progestogens in menopausal hormone therapy
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Simultaneous Determination of Selected Steroids with Neuroactive Effects in Human Serum by Ultrahigh-Performance Liquid Chromatography–Tandem Mass Spectrometry
- Epigallocatechin-Gallate (EGCG): An Essential Molecule for Human Health and Well-Being
- Amphiregulin in Fibrotic Diseases and Cancer
- Progesterone Promotes Anti-Anxiety/Depressant-like Behavior and Trophic Actions of BDNF in the Hippocampus of Female Nuclear Progesterone Receptor, but Not 5α-Reductase, Knockout Mice
- Proteomic Analysis to Identify Prospective Biomarkers of Treatment Outcome After Microvascular Decompression for Trigeminal Neuralgia: A Preliminary Study
- Anabolic–Androgenic Steroids and Brain Damage: A Review of Evidence and Medico-Legal Implications
- Amphiregulin in Fibrotic Diseases and Cancer
- Treatment of Nonclassic 11-Hydroxylase Deficiency with Ashwagandha Root
- Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome
- Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis
- The effects of methylated flavonoids on depression-like activity and pro-inflammatory cytokine thresholds in mice induced by repeated finasteride administration
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Antioxidant Constituents of Hops (Humulus lupulus L.) as Functional Raw Materials for Cosmetic Applications
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- 24-Hydroxycholesterol suppresses steroid 5α-reductase-catalyzed conversion in human glioblastoma cell lines: A novel link between brain cholesterol homeostasis and androgen metabolism
- Is Withania somnifera (Ashwagandha) a safe and effective treatment for reducing perimenopausal symptoms?
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Depression, higher level of tension induction, and impaired coping strategies in response to stress in women with PCOS correlate with clinical and laboratory indices of hyperandrogenism and not with central obesity and insulin resistance
- Inhibitory influence of agmatine on catamenial-like seizure susceptibility in progesterone withdrawn female rats
- Cinnamic acid promotes elongation of hair peg-like sprouting in hair follicle organoids via oxytocin receptor activation
- The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
- Comment on Current Investigations into the Postfinasteride Syndrome
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study
- Involvement of neurosteroids in the control of prolactin secretion in sheep under basal, stressful and pregnancy conditions
- Stem Cells Applications in Regenerative Medicine and Disease Therapeutics
- Modulating the stem cell niche for tissue regeneration